TARO Annual Working Capital
$942.30 M
-$8.58 M-0.90%
31 March 2024
Summary:
As of February 5, 2025, TARO annual working capital is $942.30 million, with the most recent change of -$8.58 million (-0.90%) on March 31, 2024. During the last 3 years, it has risen by +$147.76 million (+18.60%).TARO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Quarterly Working Capital
$942.30 M
-$31.05 M-3.19%
31 March 2024
Summary:
As of February 5, 2025, TARO quarterly working capital is $942.30 million, with the most recent change of -$31.05 million (-3.19%) on March 31, 2024. Over the past year, it has dropped by -$31.05 million (-3.19%).TARO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.9% | -3.2% |
3 y3 years | +18.6% | +18.6% |
5 y5 years | -25.6% | -24.2% |
TARO Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -47.3% | -47.3% |
Taro Pharmaceutical Industries Working Capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2024 | $942.30 M(-0.9%) | $942.30 M(-3.2%) |
Dec 2023 | - | $973.35 M(-0.8%) |
Sept 2023 | - | $981.07 M(+7.9%) |
June 2023 | - | $909.17 M(-4.4%) |
Mar 2023 | $950.88 M(+5.0%) | $950.88 M(-3.1%) |
Sept 2022 | - | $981.76 M(+0.8%) |
June 2022 | - | $973.82 M(+7.5%) |
Mar 2022 | $905.77 M(+14.0%) | $905.77 M(+7.5%) |
Dec 2021 | - | $842.45 M(+5.6%) |
Sept 2021 | - | $797.99 M(+6.2%) |
June 2021 | - | $751.62 M(-5.4%) |
Mar 2021 | $794.53 M(-39.3%) | $794.53 M(-15.3%) |
Dec 2020 | - | $938.20 M(+4.4%) |
Sept 2020 | - | $898.51 M(-3.0%) |
June 2020 | - | $926.45 M(-29.3%) |
Mar 2020 | $1.31 B(+3.5%) | $1.31 B(+5.3%) |
Dec 2019 | - | $1.24 B(-2.1%) |
Sept 2019 | - | $1.27 B(-5.5%) |
June 2019 | - | $1.34 B(+6.2%) |
Mar 2019 | $1.27 B(-24.7%) | $1.27 B(+1.8%) |
Dec 2018 | - | $1.24 B(-25.2%) |
Sept 2018 | - | $1.66 B(+1.3%) |
June 2018 | - | $1.64 B(-2.4%) |
Mar 2018 | $1.68 B(-6.1%) | $1.68 B(-0.7%) |
Dec 2017 | - | $1.69 B(-1.9%) |
Sept 2017 | - | $1.73 B(-0.2%) |
June 2017 | - | $1.73 B(-3.4%) |
Mar 2017 | $1.79 B(+9.6%) | $1.79 B(+16.0%) |
Dec 2016 | - | $1.54 B(+14.0%) |
Sept 2016 | - | $1.35 B(-6.2%) |
June 2016 | - | $1.44 B(-11.7%) |
Mar 2016 | $1.63 B(+35.6%) | $1.63 B(+3.6%) |
Dec 2015 | - | $1.57 B(+9.9%) |
Sept 2015 | - | $1.43 B(+8.4%) |
June 2015 | - | $1.32 B(+9.8%) |
Mar 2015 | $1.20 B(+50.9%) | $1.20 B(+10.9%) |
Dec 2014 | - | $1.09 B(+10.7%) |
Sept 2014 | - | $980.08 M(+16.1%) |
June 2014 | - | $844.22 M(+5.8%) |
Mar 2014 | $797.97 M(+11.3%) | $797.97 M(+8.7%) |
Dec 2013 | - | $734.43 M(-15.5%) |
Sept 2013 | - | $868.98 M(+13.7%) |
June 2013 | - | $764.11 M(+6.5%) |
Mar 2013 | $717.24 M(+57.7%) | $717.24 M(+7.4%) |
Dec 2012 | - | $667.83 M(+11.6%) |
Sept 2012 | - | $598.63 M(+15.0%) |
June 2012 | - | $520.61 M(+14.5%) |
Mar 2012 | $454.76 M(+16.3%) | $454.76 M(+16.3%) |
Dec 2011 | $391.05 M(+135.8%) | $391.05 M(+24.1%) |
Sept 2011 | - | $315.23 M(+19.8%) |
June 2011 | - | $263.15 M(+25.1%) |
Mar 2011 | - | $210.28 M(+26.8%) |
Dec 2010 | $165.85 M(+180.7%) | $165.85 M(+38.8%) |
Sept 2010 | - | $119.45 M(+50.5%) |
June 2010 | - | $79.36 M(+34.3%) |
Dec 2009 | $59.09 M | $59.09 M(+6.6%) |
Sept 2009 | - | $55.45 M(+8.1%) |
June 2009 | - | $51.30 M(+8.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2009 | - | $47.44 M(-471.4%) |
Dec 2008 | -$12.77 M(-47.8%) | -$12.77 M(-133.4%) |
Sept 2008 | - | $38.25 M(-172.3%) |
Dec 2007 | -$24.45 M(-81.2%) | - |
Dec 2006 | -$130.18 M(+146.2%) | - |
Dec 2005 | -$52.87 M(-126.2%) | -$52.87 M(-127.0%) |
Sept 2005 | - | $195.47 M(+5.1%) |
June 2005 | - | $185.94 M(+0.1%) |
Mar 2005 | - | $185.74 M(-7.9%) |
Dec 2004 | $201.59 M(-28.0%) | $201.59 M(-1.9%) |
Sept 2004 | - | $205.53 M(-14.9%) |
June 2004 | - | $241.49 M(-7.9%) |
Mar 2004 | - | $262.07 M(-6.4%) |
Dec 2003 | $279.95 M(+40.8%) | $279.95 M(+19.5%) |
Sept 2003 | - | $234.22 M(+0.3%) |
June 2003 | - | $233.50 M(+31.4%) |
Mar 2003 | - | $177.75 M(-10.6%) |
Dec 2002 | $198.87 M(+1.1%) | $198.87 M(+0.7%) |
Sept 2002 | - | $197.58 M(-0.6%) |
June 2002 | - | $198.70 M(-2.1%) |
Mar 2002 | - | $202.93 M(+3.2%) |
Dec 2001 | $196.71 M(+351.3%) | $196.71 M(+210.2%) |
Sept 2001 | - | $63.42 M(+12.4%) |
June 2001 | - | $56.44 M(+26.9%) |
Mar 2001 | - | $44.47 M(+2.0%) |
Dec 2000 | $43.59 M(+67.9%) | $43.59 M(+19.0%) |
Sept 2000 | - | $36.64 M(+30.5%) |
June 2000 | - | $28.08 M(+12.4%) |
Mar 2000 | - | $24.99 M(-3.8%) |
Dec 1999 | $25.96 M(+118.2%) | $25.96 M(+7.7%) |
Sept 1999 | - | $24.10 M(+68.5%) |
June 1999 | - | $14.30 M(+11.7%) |
Mar 1999 | - | $12.80 M(+7.6%) |
Dec 1998 | $11.90 M(+14.4%) | $11.90 M(+26.6%) |
Mar 1998 | - | $9.40 M(-9.6%) |
Dec 1997 | $10.40 M(-18.8%) | $10.40 M(-21.8%) |
Sept 1997 | - | $13.30 M(+4.7%) |
June 1997 | - | $12.70 M(+0.8%) |
Mar 1997 | - | $12.60 M(-1.6%) |
Dec 1996 | $12.80 M(-11.1%) | $12.80 M(-7.9%) |
Sept 1996 | - | $13.90 M(-4.1%) |
June 1996 | - | $14.50 M(0.0%) |
Mar 1996 | - | $14.50 M(+0.7%) |
Dec 1995 | $14.40 M(+136.1%) | $14.40 M(+136.1%) |
Dec 1994 | $6.10 M(+45.2%) | $6.10 M(+45.2%) |
Dec 1993 | $4.20 M(+5.0%) | $4.20 M(+5.0%) |
Dec 1992 | $4.00 M(+21.2%) | $4.00 M(-29.8%) |
Sept 1992 | - | $5.70 M(-6.6%) |
June 1992 | - | $6.10 M(-1.6%) |
Mar 1992 | - | $6.20 M(+87.9%) |
Dec 1991 | $3.30 M(+153.8%) | $3.30 M(+94.1%) |
Sept 1991 | - | $1.70 M(+21.4%) |
June 1991 | - | $1.40 M(-22.2%) |
Mar 1991 | - | $1.80 M(+38.5%) |
Dec 1990 | $1.30 M(-13.3%) | $1.30 M(0.0%) |
Mar 1990 | - | $1.30 M(-13.3%) |
Dec 1989 | $1.50 M(-16.7%) | $1.50 M(-16.7%) |
Dec 1988 | $1.80 M(0.0%) | $1.80 M(0.0%) |
Dec 1987 | $1.80 M | $1.80 M |
FAQ
- What is Taro Pharmaceutical Industries annual working capital?
- What is the all time high annual working capital for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual working capital year-on-year change?
- What is Taro Pharmaceutical Industries quarterly working capital?
- What is the all time high quarterly working capital for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly working capital year-on-year change?
What is Taro Pharmaceutical Industries annual working capital?
The current annual working capital of TARO is $942.30 M
What is the all time high annual working capital for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual working capital is $1.79 B
What is Taro Pharmaceutical Industries annual working capital year-on-year change?
Over the past year, TARO annual working capital has changed by -$8.58 M (-0.90%)
What is Taro Pharmaceutical Industries quarterly working capital?
The current quarterly working capital of TARO is $942.30 M
What is the all time high quarterly working capital for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly working capital is $1.79 B
What is Taro Pharmaceutical Industries quarterly working capital year-on-year change?
Over the past year, TARO quarterly working capital has changed by -$31.05 M (-3.19%)